Slc38a10 is a novel regulator of osteoblastic bone formation

Slc38a10 is a novel regulator of osteoblastic bone formation

Bibliographic Details
Main Authors:	Andrea S. Pollard, Davide Komla Ebri, Penny Sparkes, Apostolos Gogakos, John G. Logan, Natalie C. Butterfield, Victoria Leitch, J.H. Duncan Bassett, Graham R. Williams
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187220300942

Similar Items

Mitoguardin-2 deficiency results in severe osteoporosis
by: Davide Komla-Ebri, et al.
Published: (2020-10-01)

Functional validation of the osteoporosis GWAS candidate FUBP3 in knockout mice
by: Laura Watts, et al.
Published: (2020-10-01)

Fgfr3 gain-of-function mutation impacts bone homeostasis in hypochondroplasia mouse model
by: Léa Loisay, et al.
Published: (2020-10-01)

SLC38A2 provides proline to fulfill unique synthetic demands arising during osteoblast differentiation and bone formation
by: Leyao Shen, et al.
Published: (2022-03-01)

The Genetic Variability of Members of the SLC38 Family of Amino Acid Transporters (<i>SLC38A3</i>, <i>SLC38A7</i> and <i>SLC38A9</i>) Affects Susceptibility to Type 2 Diabetes and Vascular Complications
by: Paolina Crocco, et al.
Published: (2022-10-01)

p38 MAPK signalling in osteoblast differentiation
by: Edgardo eRodríguez-Carballo, et al.
Published: (2016-05-01)

Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice
by: Léa Loisay, et al.
Published: (2023-06-01)

Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6)
by: Yangzom D. Bhutia, et al.
Published: (2022-01-01)

The secreted protein augurin is a novel modulator of canonical Wnt signalling involved in osteoblast differentiation
by: Carmen Ruggiero, et al.
Published: (2022-09-01)

SLC38A6 expression in macrophages exacerbates pulmonary inflammation
by: Yizhao Peng, et al.
Published: (2023-01-01)

Mice harbouring the minor allele of the human DIO2 polymorphism (Thr92Ala) are protected against osteoarthritis
by: Natalie Butterfield, et al.
Published: (2020-10-01)

SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
by: Tyler Sniegowski, et al.
Published: (2021-03-01)

SLC38A10 Deficiency in Mice Affects Plasma Levels of Threonine and Histidine in Males but Not in Females: A Preliminary Characterization Study of SLC38A10<sup>−/−</sup> Mice
by: Frida A. Lindberg, et al.
Published: (2023-03-01)

SLC38A2 provides proline and alanine to regulate postnatal bone mass accrual in mice
by: Leyao Shen, et al.
Published: (2022-09-01)

SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
by: Myeong Jin Kim, et al.
Published: (2023-10-01)

Differential Expression of SLC25A38 Gene in Patients of Acute Lymphoblastic Leukaemia
by: PRITAM PRAKASH, et al.
Published: (2022-01-01)

Role of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma
by: Ines Böhme-Schäfer, et al.
Published: (2022-04-01)

Comprehensive analysis of the biological function and immune infiltration of SLC38A2 in gastric cancer
by: Liang Zhu, et al.
Published: (2023-03-01)

Picornavirus infection enhances aspartate by the SLC38A8 transporter to promote viral replication.
by: Huisheng Liu, et al.
Published: (2023-02-01)

Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms
by: Shen, Kuang, et al.
Published: (2021)

Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis
by: Zhongxiao Wang, et al.
Published: (2022-12-01)

SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma
by: Zhongyi Fan, et al.
Published: (2022-04-01)

Knockdown of SLC38 Transporter Ortholog – CG13743 Reveals a Metabolic Relevance in Drosophila
by: Tanya Aggarwal, et al.
Published: (2020-01-01)

SLC38A4 Amino Acid Transporter Expression Is Significantly Lower in Early Preterm Intrauterine Growth Restriction Complicated Placentas
by: Elif Kadife, et al.
Published: (2022-12-01)

Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling.
by: Yougen Wu, et al.
Published: (2015-01-01)

Slc38a9 Deficiency Induces Apoptosis and Metabolic Dysregulation and Leads to Premature Death in Zebrafish
by: Xiya Wu, et al.
Published: (2022-04-01)

Slc38a1 Conveys Astroglia-Derived Glutamine into GABAergic Interneurons for Neurotransmitter GABA Synthesis
by: Tayyaba Qureshi, et al.
Published: (2020-07-01)

Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways
by: Wanachewin Orawan, et al.
Published: (2012-05-01)

Liggaamsimbolisering in Psalm 38
by: J.H. Coetzee
Published: (2000-08-01)

Fournival and propertius: A note on the early history of Leiden Voss. Lat. O 38
by: Butterfield, D, et al.
Published: (2011)

Induction of Oxidative Stress and Ferroptosis in Triple-Negative Breast Cancer Cells by Niclosamide via Blockade of the Function and Expression of SLC38A5 and SLC7A11
by: Marilyn Mathew, et al.
Published: (2024-02-01)

Accelerating functional gene discovery in osteoarthritis
by: Natalie C. Butterfield, et al.
Published: (2021-01-01)

Publisher Correction: Accelerating functional gene discovery in osteoarthritis
by: Natalie C. Butterfield, et al.
Published: (2021-05-01)

SLC38A5 aggravates DC-mediated psoriasiform skin inflammation via potentiating lysosomal acidification
by: Leqing Zhu, et al.
Published: (2023-08-01)

Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
by: Plovanich, M. E., et al.
Published: (2015)

Discoidin Domain Receptor 1 Regulates Runx2 during Osteogenesis of Osteoblasts and Promotes Bone Ossification via Phosphorylation of p38
by: Liang-Yin Chou, et al.
Published: (2020-09-01)

KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK
by: Laura Salvadori, et al.
Published: (2022-07-01)

Insights into the Interaction of Lysosomal Amino Acid Transporters SLC38A9 and SLC36A1 Involved in mTORC1 Signaling in C2C12 Cells
by: Dan Wang, et al.
Published: (2021-09-01)

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
by: Morotti, M, et al.
Published: (2019)

Novel Biallelic Variants and Phenotypic Features in Patients with <i>SLC38A8</i>-Related Foveal Hypoplasia
by: Elena R. Schiff, et al.
Published: (2021-01-01)